Home
Name
AP-23573
Alternate Names
AP 23573
AP23573
Abbreviations
None
Category
Chemotherapy
Subcategory
Cytostatic agent--antiangiogenic agent
NSC Number
None
Primary Site
Lymphoma
other cancer
Histology
None
Remarks
Phase I Degradation of PKB/Akt protein by inhibition of the VEGF receptor/mTOR pathway in endothelial cells. Ariad Pharmaceuticals.
Coding
This drug should be coded
